Pharma-Bio Serv, Inc. reported earnings results for the second quarter and six months ended April 30, 2024. For the second quarter, the company reported sales was USD 2.38 million compared to USD 4.56 million a year ago. Net loss was USD 0.213817 million compared to net income of USD 0.404654 million a year ago. Basic loss per share from continuing operations was USD 0.009 compared to basic earnings per share from continuing operations of USD 0.018 a year ago. Diluted loss per share from continuing operations was USD 0.009 compared to diluted earnings per share from continuing operations of USD 0.018 a year ago.
For the six months, sales was USD 4.76 million compared to USD 8.8 million a year ago. Net loss was USD 0.484536 million compared to net income of USD 0.831086 million a year ago. Basic loss per share from continuing operations was USD 0.021 compared to basic earnings per share from continuing operations of USD 0.036 a year ago. Diluted loss per share from continuing operations was USD 0.021 compared to diluted earnings per share from continuing operations of USD 0.036 a year ago.